Displaying 1 - 6 of 6
| Active Ingredient | THALIDOMIDE |
| Therapeutic Class | BIOLOGIC RESPONSE MODIFIER |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | ALENDRONATE |
| Therapeutic Class | BONE RESORPTION INHIBITORS |
| Indications | Treatment and p revention of osteop orosis. |
| Caution |
Abdominal pain, dyspepsia, diarrhoea or constipation. Patients should be instructed to avoid lying down for at least 30 minutes following administration of alendronate to minimize potential esophageal More ... |
| Dose Range | 70mg once weekly with a full glass of water on morning on an empty stomach, at least 30 minutes before breakfast and any other oral medication. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | IBANDRONIC ACID |
| Therapeutic Class | BONE RESORPTION INHIBITORS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | RISEDRONATE |
| Therapeutic Class | BONE RESORPTION INHIBITORS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | RISENDRONATE |
| Therapeutic Class | BONE RESORPTION INHIBITORS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | ZOLENDRONIC ACID |
| Therapeutic Class | BONE RESORPTION INHIBITORS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |